S-Network Medical Breakthroughs Index
An index of small and mid-cap biotechnology stocks listed on US stock exchanges that have one or more drugs in either Phase II or Phase III US FDA clinical trials.
Quick Links
| As July 26, 2024 | Index Level | 3-Month | 6-Month | 1-Year | YTD |
| Price Return | 8,658.0 | 19.4% | 17.1% | 23.3% | 16.7% |
| Total Return | 9,206.9 | 19.4% | 17.1% | 23.3% | 16.7% |
| Net Total Return | 9,188.2 | 19.4% | 17.1% | 23.3% | 16.7% |
| Index Level | 8,658.0 |
|---|---|
| 3-Month | 19.4% |
| 6-Month | 17.1% |
| 1-Year | 23.3% |
| YTD | 16.7% |
| Index Level | 9,206.9 |
|---|---|
| 3-Month | 19.4% |
| 6-Month | 17.1% |
| 1-Year | 23.3% |
| YTD | 16.7% |
| Index Level | 9,188.2 |
|---|---|
| 3-Month | 19.4% |
| 6-Month | 17.1% |
| 1-Year | 23.3% |
| YTD | 16.7% |
As of July 26, 2024
Characteristics
| Index Symbol (Price Return) | PMBI |
| Index Symbol (Total Return) | PMBITR |
| Index Symbol (Net Total Return) | PMBINT |
| Number of Constituents | 100 |
| Market Capitalization | $152 Billion |
| Adjusted Market Capitalization | $110 Million |
| Rebalancings | Quarterly |
| Dividend Yield | 0.00% |
Composition
Top Index Constituents
As of July 27, 2024
Interested in Market Data packages?
VettaFi's indexes are widely used by financial firms, industry stakeholders and professionals to support a variety of business functions. We offers a range of end-of-day and historical index data subscriptions.
Contact Us